Compare GERN & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GERN | FOR |
|---|---|---|
| Founded | 1990 | 2005 |
| Country | United States | United States |
| Employees | 229 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2007 |
| Metric | GERN | FOR |
|---|---|---|
| Price | $1.55 | $25.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $2.17 | ★ $31.75 |
| AVG Volume (30 Days) | ★ 17.1M | 105.0K |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.30 |
| Revenue | N/A | ★ $1,662,400,000.00 |
| Revenue This Year | $26.91 | $0.52 |
| Revenue Next Year | $43.75 | $7.72 |
| P/E Ratio | ★ N/A | $84.40 |
| Revenue Growth | N/A | ★ 10.14 |
| 52 Week Low | $1.04 | $18.00 |
| 52 Week High | $2.01 | $30.74 |
| Indicator | GERN | FOR |
|---|---|---|
| Relative Strength Index (RSI) | 48.18 | 41.30 |
| Support Level | $1.24 | $25.25 |
| Resistance Level | $1.70 | $26.06 |
| Average True Range (ATR) | 0.10 | 0.75 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 37.50 | 59.64 |
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.